Cargando…
Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC
INTRODUCTION: Compared to other types of breast cancer, triple-negative breast cancer (TNBC) does not effectively respond to hormone therapy and HER2 targeted therapy, showing a poor prognosis. There are currently a limited number of immunotherapeutic drugs available for TNBC, a field that requires...
Autores principales: | Wu, Haoming, Feng, Jikun, Zhong, Wenjing, Zouxu, Xiazi, Xiong, Zhengchong, Huang, Weiling, Zhang, Chao, Wang, Xi, Yi, Jiarong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043239/ https://www.ncbi.nlm.nih.gov/pubmed/36999020 http://dx.doi.org/10.3389/fimmu.2023.1151800 |
Ejemplares similares
-
Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC
por: Yi, Jiarong, et al.
Publicado: (2021) -
Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer
por: Feng, Jikun, et al.
Publicado: (2022) -
Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021) -
A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern
por: Xiong, Zhenchong, et al.
Publicado: (2022) -
Comprehensive analysis of the NME gene family functions in breast cancer
por: Wu, Haoming, et al.
Publicado: (2020)